Current Issue


Review finds blood pressure-lowering effects weaker in patients with type 2 diabetes

Absolute risk reductions did not differ substantially between people with and without type 2 diabetes because of the higher absolute cardiovascular risk among those with the condition, according to a new meta-analysis.

Comprehensive telehealth approach improved HbA1c in type 2 diabetes

Compared with a simpler approach of telemonitoring and care coordination, an intervention that added self-management and diet/activity support, medication management, and depression care improved outcomes in veterans with poorly controlled type 2 diabetes, a trial found.

Glucose-lowering treatment after type 2 diabetes diagnosis differed by race/ethnicity

Among 77,199 patients in a U.S. health system with a new diagnosis of diabetes from 2005 to 2016, 47% started a diabetes medication within 12 months. Prevalence differed by race and ethnicity, although the difference was mitigated by variation in HbA1c levels.

MKSAP quiz: Gestational diabetes treatment

This month's quiz asks readers to evaluate a 34-year-old woman after a recent diagnosis of gestational diabetes. She is 28 weeks pregnant and since her diagnosis, she has improved her diet, is exercising regularly, and is monitoring her glucose levels.

Spotlight on older diabetes patients

Recent studies of older patients with diabetes described the effectiveness of a lifestyle intervention, low use of continuous glucose monitoring, and high risk of falls with hypoglycemia.

In diabetes, some statins reduce non–HDL-C better than others vs. placebo

A review reaffirmed well-known information about the potency of commonly prescribed statins and suggested that non–high-density lipoprotein cholesterol (HDL-C) may be a better measure of cardiovascular risk than low-density lipoprotein cholesterol in patients on statins, an ACP Journal Club commentary said.

Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19

Although the effect of COVID-19 on diabetes incidence is small, according to the study, the affected population could be large, given that many at-risk people have had acute COVID-19, an ACP Journal Club commentary said.